Dr. Niglio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Perlmutter Cancer Center
160 East 34th Street
New York, NY 10016
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2016 - 2019
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2014 - 2016
- Rutgers Robert Wood Johnson Medical SchoolClass of 2012
Certifications & Licensure
- NY State Medical License 2018 - 2025
- MD State Medical License 2020 - 2023
- PA State Medical License 2013 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsAdjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2025-01-02 - Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal, Andre R Kydd
Journal of Clinical Oncology. 2024-09-01 - 7 citationsPembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, ...Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, Neal D Shore, Joost L Boormans
The Lancet. Oncology. 2024-06-01
Press Mentions
- Patients with Bladder Cancer May Avoid Removal of Extra Lymph Nodes, Study FindsJune 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: